P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life

BJH - volume 8, issue Abstract Book BHS, february 2017

A. Pistone , M. Maerevoet MD, S. Wittnebel MD, PhD, M. Vercruyssen MD, S. Buntinx , C. Spilleboudt MD, D. Bron MD, PhD, N. Meuleman MD, PhD

Read more

PP2.4 Identifying infectious triggering factors even in the presence of known predisposing diseases is mandatory in hemophagocytic lymphohistiocytosis, a review of 35 cases in two Belgian hospitals

BJH - volume 7, issue Abstract Book BHS, january 2016

S. Buntinx , P. Antoine , B. Bailly MD, I. Beukinga , D. Bron MD, PhD, V. De Wilde MD, PhD

Read more